They evaluated MALAT1 expression by comparing the mononuclear bone marrow cells of MM patients in different disease states compared to healthy individuals, and demonstrated that the high serum levels of MALAT1 detected in MM patients decreased significantly in post-treatment patients, showing serum levels similar to those of healthy individuals and a prolonged progression-free survival [118]. Here, MALAT1 is linked to Miyoshi myopathy.